Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
843
¥100 million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportThird quarter of the fiscal year ended December 20247 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥12,777 100 million+7.1%
Operating profit¥1,394 100 million+19.4%
Ordinary income¥1,395 100 million +18.7%profit before tax for the quarter
Net income¥833 100 million +24.0%profit for the quarter attributable to owners of the parent
Gross Profit Margin38.5%
Operating profit margin10.9%
Selling, general and administrative expenses¥3,510 100 million
Full-year earnings forecast
Revenue
¥16,870 100 million
Operating profit
¥1,535 100 million
Income before taxes
¥1,530 100 million
Profit for the period attributable to owners of the parent
¥865 100 million
EBITDA
¥2,390 100 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Segment profit of the Japan business2023年第3四半期セグメント利益373億円→売上収益増減+191億円、原価増減△52億円、販売促進費・広告宣伝費増減△8億円、その他△32億円→2024年第3四半期セグメント利益471億円
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
US dollars149
Euro163
British pound193
Singapore dollars113
Thai baht4.3
Vietnamese dong0.01
ニュージーランドドル92
Australian dollar100
Key KPIsA metric the company considers important as a management benchmark.
- EBITDA¥1,973 100 millionYear on year against the same period last year+15.7%
- EBITDA margin15.4 %Year on year against the same period last year+1.1%
- Total sales volume in the Japan business348.1 million casesYear on year against the same period last year-1.0%
- 特定保健用食品および機能性表示食品販売数量31.7 million casesYear on year against the same period last year+7.0%
- D/E ratio-0.05 times
Segment results
Japan
Revenue
¥5,578 100 million+3.5%
EBITDA
¥725 100 million+18.2%
Segment profit
¥471 100 million+26.4%
Asia Pacific
Revenue
¥2,950 100 million+7.8%
EBITDA
¥514 100 million+14.6%
Segment profit
¥380 100 million+17.6%
Europe
Revenue
¥2,865 100 million+9.8%
EBITDA
¥609 100 million+16.1%
Segment profit
¥490 100 million+17.3%
Americas
Revenue
¥1,384 100 million+15.2%
EBITDA
¥220 100 million+15.0%
Segment profit
¥176 100 million+16.3%
Financial targets
ROE
2023 Actual8.1 %
2024年予想7.7 %
Debt-to-equity ratio
2023 Actual-0.04 times
2024年予想-0.05 times
Capital expenditures
¥1,410 100 million
Payout ratio
40 %
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Third quarter of the fiscal year ended December 2024 |
| Net Sales | ¥12,777 100 million (YoY +7.1%) |
| Operating profit | ¥1,394 100 million (YoY +19.4%) |
| Ordinary income | ¥1,395 100 million (profit before tax for the quarter) (YoY +18.7%) |
| Net income | ¥833 100 million (profit for the quarter attributable to owners of the parent) (YoY +24.0%) |
| Gross Profit Margin | 38.5% |
| Operating profit margin | 10.9% |
| Selling, general and administrative expenses | ¥3,510 100 million |
| Full-year earnings forecast | Revenue ¥16,870 100 million / Operating profit ¥1,535 100 million / Income before taxes ¥1,530 100 million / Profit for the period attributable to owners of the parent ¥865 100 million / EBITDA ¥2,390 100 million |
| Segment results | Japan Revenue ¥5,578 100 million (YoY +3.5%) / EBITDA ¥725 100 million (YoY +18.2%) / Segment profit ¥471 100 million (YoY +26.4%) / Asia Pacific Revenue ¥2,950 100 million (YoY +7.8%) / EBITDA ¥514 100 million (YoY +14.6%) / Segment profit ¥380 100 million (YoY +17.6%) / Europe Revenue ¥2,865 100 million (YoY +9.8%) / EBITDA ¥609 100 million (YoY +16.1%) / Segment profit ¥490 100 million (YoY +17.3%) / Americas Revenue ¥1,384 100 million (YoY +15.2%) / EBITDA ¥220 100 million (YoY +15.0%) / Segment profit ¥176 100 million (YoY +16.3%) |
| Breakdown of Factors Affecting the Change | Segment profit of the Japan business 2023年第3四半期セグメント利益373億円→売上収益増減+191億円、原価増減△52億円、販売促進費・広告宣伝費増減△8億円、その他△32億円→2024年第3四半期セグメント利益471億円 |
| Key KPIs | EBITDA ¥1,973 100 million, EBITDA margin 15.4 %, Total sales volume in the Japan business 348.1 million cases, 特定保健用食品および機能性表示食品販売数量 31.7 million cases, D/E ratio -0.05 times |
| Assumptions Underlying the Business Outlook | Exchange rate US dollars 149 / Euro 163 / British pound 193 / Singapore dollars 113 / Thai baht 4.3 / Vietnamese dong 0.01 / ニュージーランドドル 92 / Australian dollar 100 |
| Financial targets | ROE 2023 Actual 8.1 % / 2024年予想 7.7 % / Debt-to-equity ratio 2023 Actual -0.04 times / 2024年予想 -0.05 times |
| Payout ratio | 40 % |
| Capital expenditures | ¥1,410 100 million |
Items this document does not state (14)
Results for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.会社が示した日本事業の営業利益増減要因は、売上収益増加が191億円、原価増加が52億円の減益要因、販売促進費・広告宣伝費増加が8億円の減益要因、その他が32億円の減益要因。売上収益は日本、アジアパシフィック、欧州、米州の全地域で増加した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.